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Abstract
Background: Rescuing amphibian diversity is an achievable conservation challenge. Disease mitigation is one
essential component of population management. Here we assess existing disease mitigation strategies, some in
early experimental stages, which focus on the globally emerging chytrid fungus Batrachochytrium dendrobatidis. We
discuss the precedent for each strategy in systems ranging from agriculture to human medicine, and the outlook
for each strategy in terms of research needs and long-term potential.
Results: We find that the effects of exposure to Batrachochytrium dendrobatidis occur on a spectrum from transient
commensal to lethal pathogen. Management priorities are divided between (1) halting pathogen spread and
developing survival assurance colonies, and (2) prophylactic or remedial disease treatment. Epidemiological models of
chytridiomycosis suggest that mitigation strategies can control disease without eliminating the pathogen. Ecological
ethics guide wildlife disease research, but several ethical questions remain for managing disease in the field.
Conclusions: Because sustainable conservation of amphibians in nature is dependent on long-term population
persistence and co-evolution with potentially lethal pathogens, we suggest that disease mitigation not focus
exclusively on the elimination or containment of the pathogen, or on the captive breeding of amphibian hosts.
Rather, successful disease mitigation must be context specific with epidemiologically informed strategies to
manage already infected populations by decreasing pathogenicity and host susceptibility. We propose population
level treatments based on three steps: first, identify mechanisms of disease suppression; second, parameterize
epizootiological models of disease and population dynamics for testing under semi-natural conditions; and third,
begin a process of adaptive management in field trials with natural populations.
Introduction
“The Amphibian Conservation Summit was called
because it is morally irresponsible to document amphi-
bian declines and extinctions without also designing and
promoting a response to this global crisis.” [1]
“Our focus on crisis has hampered conservation biol-
ogy in achieving a scale of action required to match the
world’s environmental problems. Despite our best efforts
to launch our cause into the mainstream culture, the
world is suffering from crisis fatigue.” [2]
Conservation biology is often characterized as a
“doom and gloom” crisis discipline, a field of study that
decries the loss of biodiversity and places blame on con-
tributory human actions [3]. A prolonged sense of crisis
and guilt with a continual focus on extinction is depres-
sing. Such negative social perceptions of biodiversity
conservation may exhaust public good will and become
demotivating [4]. The effort to inspire and energize con-
servation biology can therefore benefit from fresh vision
and the hope of restoration (Figure 1). Building on solid
documentation and explanations for the loss of amphi-
bians around the world, conservation research is now
focusing on methods to halt and reverse this trend.
Amphibian ecologists are entering a period of action in
response to catastrophe [5].
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Figure 1 Some of the rediscovered species in Costa Rica including. A. Craugastor ranoides, B. Atelopus varius, C. Lithobates vibicarius, and D.
Pristimantis lemur. Locality data are retained to discourage poaching. E. Climatic refuge in Costa Rica indicated by arrow. The core distribution of
Batrachochytrium dendrobatidis (Bd) occurs in humid environments and coincides with the distribution of most declining populations of
amphibians. Low abundance relict populations are being rediscovered within Bd enzootic zones, often with subclinical infections. Other species
are found outside Bd enzootic zones. Healthy populations, in which a susceptible species maintained high abundance, were found at the edge
of the distribution of the robber frog, Craugastor ranoides, in a climatic refuge [138]. Puschendorf et al. ([139]; including details of the bioclimatic
model pictured in E) hypothesized that this relict population in the dry forest of Santa Elena Peninsula, Costa Rica, survives because climatic
conditions in that habitat make pathogen establishment or persistence on hosts less likely.
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Already, there are several successful amphibian
conservation programs that have addressed problems of
invasive species and habitat modification. For example,
the removal of introduced trout from lakes in the Sierra
Nevada mountains allowed recolonization of native
frogs, reversing the effects of a major factor in popula-
tion declines [6]. Another example is the restoration of
wetlands and habitat corridors that clearly benefit
amphibian populations in human altered landscapes
[7,8]. One particularly unique program is to conserve
the Kihansi spray toad (Nectophrynoides asperginis)
from the Udzungwa Mountains, Tanzania. Large scale
sprinkler systems were installed to compensate for water
flow diverted by a hydroelectric dam. The managed
habitat supported spray toads temporarily until a flood,
and likely the disease chytridiomycosis, caused their
extinction in the wild [9,10]. The demise of the Kihansi
spray toad unfortunately demonstrates that factors caus-
ing population decline can act synergistically, often
amplifying the effects of disease [11].
Chytridiomycosis is caused by the fungus Batracho-
chytrium dendrobatidis (Bd), an emerging pathogen that
colonizes amphibian skin [12,13] (Figure 2). This disease
is a focus of many amphibian conservation efforts
because of its nearly global distribution http://www.Bd-
maps.net/ with recorded epizootics on several continents
[1,14]. The impacts of chytridiomycosis differ radically
among amphibian species and populations. Some are
unaffected by Bd infection and act as carriers of the
fungus [15,16] (e.g. bullfrogs, Rana catesbeiana). Some
species tolerate a chronic, low level of infection, or
experience a relatively slow population decline [17-19]
(e.g. boreal toads, Bufo boreas) and some species experi-
ence severe, high levels of infection and acute popula-
tion decline [20,21] (e.g. Panama poison dart frogs,
Colostethus panamensis). There is evidence that these
severe outbreaks can lead to the collapse of entire
amphibian faunas including regional and global
extinction [22-24] (e.g. Bob’s robber frogs, Craugastor
punctariolus).
Subsequent to disease emergence, natural recovery of
populations is limited, regional amphibian diversity is
homogenized [25], ecosystems are altered [26-29], and
Bd becomes an established enzootic pathogen [30],
often persisting in reservoir amphibian host species
[16,17,31]. At these Bd enzootic locations, factors lead-
ing to lethal chytridiomycosis are not well understood,
but local ecological context, particularly climate, is criti-
cal [18,32-36]. Although chytridiomycosis has rightly
come to be regarded as “an alarming model system for
disease-driven extinction...” [20], we rather view chytri-
diomycosis as an opportunity to test wildlife disease
mitigation approaches and a model system to investigate
disease dynamics in ecological systems.
Aims of Disease Mitigation
Conservation priorities for amphibians threatened by
chytridiomycosis are currently structured around pre-
venting pathogen spread to unexposed populations,
establishing ex situ assurance colonies, and developing
in situ prophylactic treatment or remedial disease strate-
gies [1,37-39]. No single solution is appropriate for all
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Figure 2 Detection of Batrachochytrium dendrobatidis (Bd) and
chytridiomycosis. (A) infectious Bd zoospore 1000 × magnification
stained with congo red. Infectious zoospores in the environment
[20,229-231] or in association with amphibian skin may meet with
host resistance mechanisms such as mucosal antibodies,
antimicrobial skin peptides, or mutualistic bacteria [61,127,180,205].
(B) Small rod-shaped bacteria associated with sloughed skin from
Rana muscosa are stained red with propidium iodide. Larger Bd
zoosporangia are stained blue with calcofluor white. (C) Bd infecting
frog skin 1000 × magnification stained with calcofluor white and
propidium iodide. (D) A healthy infected frog, Pelophylax lessonae.
(E) A diseased frog with chytridiomycosis. Note the skin shedding in
water and splayed legs. If keratinized cells become infected,
infections may be controlled by host responses that reduce Bd
population growth resulting in host tolerance of low-intensity
infection and no clinical signs of disease, as in (D). An alternative
outcome of infection is uncontrolled Bd growth that leads to
clinical chytridiomycosis (Figure 2E; reviewed in [207]). A simple
definition of disease is uncontrolled infection.
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amphibian species with their rich diversity of life his-
tories and habitats [40]. Here, we discuss seven popula-
tion-level mitigation strategies against Bd. These
strategies may have specific regional applications
depending on social and environmental contexts. In
most cases, local elimination of potentially harmful
microorganisms is not practical because of the contin-
ued risk of pathogen reintroduction. We emphasize that
elimination of Bd is not necessarily the desired manage-
ment endpoint for the purposes of amphibian conserva-
tion because preventing disease does not always require
eliminating exposure to pathogens. Furthermore, pre-
venting population declines does not necessarily require
eliminating disease.
The presence of a parasite or pathogen does not
necessarily cause disease or amphibian population
declines. There are many examples of serious pathogens
that are “opportunistic” and normally present in healthy
individuals. In amphibians, these include common envir-
onmental bacteria such as Aeromonas, Flavobacterium,
Pseudomonas, Acinetobacter, and Serratia [41]. In
humans, opportunistic fungal pathogens include Can-
dida albicans, a commensal fungus found in the gastro-
intestinal tract of 40 - 60% of people, causing severe
candidiasis only in immunocompromised patients
[42,43]. Other medical examples are instructive [44-47],
and demonstrate that a pathogen is not always patho-
genic. Here we illustrate the opportunistic nature of Bd
(Table 1, Figure 2), and suggest that the goal of wildlife
management should be the preservation of viable, even
if colonized, populations rather than the elimination of
the pathogen.
Within the spectrum from transient commensal to
acute lethal disease, the sublethal effects of Bd exposure
may be considered as mild controlled infections or as
latent effects (originating from an earlier exposure but
expressed in hosts without infection after a period of
clinical quiescence [48]; Table 1, Figure 2). Controlled
infections or even transient exposure to Bd may cause a
reduction in mass or growth rate [34,49-51] or other
consequences that reduce host fitness. Since these
effects are not due to an uncontrolled infection, the ani-
mals do not have chytridiomycosis by our simple defini-
tion (Figure 2). Rather than aclinical chytridiomycosis,
measurable clinical signs with no detectable Bd coloni-
zation may be the result of an effective, yet costly,
immune defense.
An alternative framework defines the disease chytri-
diomycosis in terms of host damage caused by Bd, irre-
spective of Bd infection status. That is, microbial
pathogenesis is the outcome of microbe, host, and envir-
onmental contributions and interactions (Figure 3). This
ecologically-oriented damage-response framework [52]
takes into consideration that pathogen strain, environ-
mental conditions, and host behavior, genetics, and
immunity can affect the disease (or damage) response.
This concept incorporates a threshold burden of Bd
infection that leads to death [17,21,53], and the potential
for immunopathology (damage caused by the host
immune response rather than the pathogen) that can
lead to host damage irrespective of infection intensity
[34,52,54,55]. In Figure 3, we model the relatively
greater damage caused by Bd when host responses are
too weak or too strong, and how this response can differ
Table 1 The ecology of Batrachochytrium dendrobatidis (Bd) opportunism indicates disease risk factors critical for
focused management.
Pathogenicity A review of the pathogenesis of Bd leads to the conclusion that the fungus is well adapted to the skin of amphibian hosts [228].
However, Bd can also be detected in the water column [218,229,230], and on moist substrates [20,231]. Although saprophytic growth
is not strongly indicated, Bd forms biofilms in culture that could, hypothetically, improve survival under harsh or variable
environmental conditions. Environmental longevity may entail life-history trade-offs that occur in response to culture conditions of
temperature and nutrient availability [160,161], and specific host adaptations are not unlikely. Bd appears to exhibit chemotaxis
toward favorable substrates [232], or away from unfavorable substrates (B. Lam & R.N. Harris, unpublished). Virulence of Bd appears to
vary with the strain in laboratory experiments [49,68,69], although the determinants of differential virulence are not well understood
[228].
Susceptibility Susceptibility to amphibian chytrid occurs on a spectrum. Bd is an opportunistic pathogen that can be present transiently, cause
sublethal host damage, or cause uncontrolled infections leading to death. Developmental stages of amphibians are not equally
affected by exposure to Bd, and disease outbreaks of some species are associated with metamorphosis [206,233,234]. Figure 2
illustrates several outcomes of exposure to Bd. The contribution of immunopathology to host damage has not been characterized,
however, at least in the cases of Bufo bufo and Bufo boreas tadpoles, immunopathology or physiological trade-offs can result from
exposure to Bd even without infection [34,235] (Figure 3). Amphibian susceptibility is extremely sensitive to environmental context.
Environment Outbreaks of chytridiomycosis are often the result of environmental forcing [36]. For example, although Bd can be widespread across
a landscape, mid- to high-elevation populations are often more severely affected by disease than low-elevation populations of the
same species. Seasonal disease dynamics are another manifestation of environmental context-dependency, and high infection
prevalence is often associated with cool seasons (reviewed in [207]). Climatic variability is also associated with epizootic disease
dynamics [67]. A growing number of studies demonstrates that exposure to Bd does not always cause infection, and many species
and regions appear to be unaffected by disease [64,207,236] (Figure 1). This begs the crucial question for disease management:
What factors lead to host protection?
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across environmental gradients. This ecological immu-
nology framework is ideal for chytridiomycosis mitiga-
tion because some strategies to reduce disease focus on
environmental context or host behavior/immunology,
rather than on limiting the pathogen.
Increasing numbers of studies show that some
amphibians can clear Bd infections (Table 2), and in at
least one study, can reduce infection loads [56]. This
can be dependent on environmental conditions and
host behavior [19,57], life-history strategy [34], or an
immune reaction that suppresses infection intensity
after a peak between 7 - 40 days after exposure
[57-61]. Catastrophic mortalities may be less common
once the pathogen is an established enzootic. Although
severe chytridiomycosis and amphibian mortality, as
with many wildlife diseases [62], is notoriously difficult
to detect in the field, severe chytridiomycosis is rarely
observed in many high Bd prevalence amphibian popu-
lations [17,18,57,63,64].
Disease management in these seemingly commensal
cases or enzootic areas remains important for several
reasons. First, population growth or amphibian abun-
dance may be suppressed by enzootic Bd [18,19,57].
Second, Bd exposure and infection has sublethal costs
[50,65,66]. Third, changing environmental conditions
[67] or more virulent strains [49,68,69] may disrupt
the temporarily commensal relationship between
amphibian host and Bd, as with other opportunistic
pathogens. Thus, the experimental disease mitigation
strategies described below are designed for both
pathogen naïve populations and persistently infected
populations with a view toward epidemiological mod-
eling and adaptive management of an opportunistic
pathogen.
Experimental disease mitigation strategies
Because it is too early for a review of experimental
results, this section is intended to focus on the concep-
tual stages of designing effective population-level disease
management strategies. Each section below refers to simi-
lar management practices for human, veterinary, or wild-
life diseases, discusses the mechanism of the strategy
(Figure 4: resistance, tolerance, infectivity, virulence), and
presents an outlook on the potential usefulness of the
strategy for amphibians.
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Figure 3 A conceptual model, developed here, for an
ecological damage-response framework of B. dendrobatidis
(Bd) pathogenicity. At either extreme of host response the host
damage (disease) progresses toward mortality. At mid-levels of host
response to Bd there may be no host damage (subclinical infection),
depending on the environmental context. Environmental gradients
may include elevation, temperature, temperature variability,
pesticide concentration, intensity of co-infection, or other factors.
Shown here is a reduced damage-response curve at low
environmental humidity. Theoretically, chytridiomycosis is
suppressed where environmental conditions are not conducive to
Bd, but under some environmental conditions host defenses
become critical for control of chytridiomycosis. Other damage-
response curve shapes are possible for this opportunistic pathogen.
Table 2 Studies that show clearance of Batrachochytrium dendrobatidis (Bd) from infected amphibian hosts.
Reference Amphibian species Lab or field Temperature
Woodhams et al. [90] Litoria chloris Lab 2 d × 8 hr at 37°C
Berger et al. [58] Mixophyes fasciolatus Lab Constant 27°C
Retallick and Miera [49] Pseudacris triseriata Lab 5 d at 32°C
Bishop et al. [59] Leiopelma archeyi Lab Constant 15°C
Becker and Harris [51] Plethodon cinereus Lab Constant 17°C
Kriger and Hero [237] Litoria wilcoxii Field Natural
Corn [238] Bufo boreas Field Natural
Murray et al. [147] Litoria pearsoniana Field Natural
Pilliod et al. [19] Bufo boreas Field Natural
Briggs et al. [17] Rana muscosa Field Natural
Voordouw et al. [239] Rana pipiens Field Natural
Geiger et al. [91] Alytes obstetricans Lab 5 d at 28°C
Márquez et al. [240] Hypsiboas crepitans Lab Constant 23°C
Chatfield & Richards-Zawacki [92] Rana catesbeiana and Acris crepitans Lab 10 d at 30°C
Clearance of Bd from marked individuals in field studies may have been caused by fluctuations in seasonal environmental conditions, but other factors are
possible.
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Reducing host density to prevent disease
outbreaks
Reducing the density of susceptible hosts in a popula-
tion by culling or translocating individuals may limit
pathogen transmission and infectious doses, thus redu-
cing the risk of disease outbreak [70,71]. Culling of live-
stock is often used to prevent economically destructive
and zoonotic disease outbreaks such as foot and mouth
disease (virus [72]), pandemic influenza (H5N1 influenza
A virus [73]), or Johne’s disease (Mycobacterium avium
subsp. paratuberculosis [74]). Reducing host densities in
wildlife is also common for large mammals such as Afri-
can elephants, American bison and elk, or kangaroos,
feral horses and camels in Australia. Though culling can
be controversial [75] or ineffective (e.g. for suppression
of Tasmanian devil facial tumor disease [76], or for sup-
pression of white-nose syndrome in bats [77]), this
approach may be particularly useful for managing spatial
distribution and connectivity within host metapopula-
tions and was used successfully against rinderpest [78].
Since field experiments suggested that transmission of
Bd may be host density dependent [79], reducing the
susceptible host population at a predicted outbreak site
may reduce disease risk. In one trial, Rana muscosa den-
sities were reduced by translocating uninfected hosts to
habitats that formerly sustained populations, rather than
culling. These preliminary experiments in the California
Sierra Nevada have not been particularly successful at
preventing outbreaks or restoring populations (V.T. Vre-
denburg, R.A. Knapp pers. comm.).
Treating amphibian hosts and habitats
Limiting the prevalence of infection or the infectious
dose accessible in the environment by treating individual
hosts or habitats may reduce pathogenicity and prevent
disease outbreak. Perhaps one of the oldest and most
common strategies against fungal diseases is agricultural
fungicides [80,81]. Antibiotics [82] and salt [83] against
fungal diseases are commonly used in aquaculture and
for veterinary treatments of fish and amphibians [84].
Besides chemical treatments, management including
drainage of entire wetland systems is not unordinary for
control of mosquito vectors of human diseases [85,86].
In vitro, Bd is susceptible to drying, salt, and a broad
range of antibiotics and chemicals [87]. Longevity of
zoospores is dependent on temperature (Figure 5A), and
Bd in sterile lake water can remain infective for up to
seven weeks in state of slowed development, rather than
saprophytic growth, until conditions improve [88]. Com-
peting microbes and predators can also reduce longevity
of the pathogen [89] (Figure 5B). Infected hosts have
been successfully treated with heat [49,90-92] or antibio-
tic applications [93,94].
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Figure 4 Four categories of host-pathogen dynamics. Arrows
indicate the desired direction for an effective disease mitigation
strategy. Here infection and the effects of infection are
distinguished, and the host-pathogen interaction is placed within an
environmental context. The epidemiological triad of environment,
host, and pathogen produces complex interactions affecting health
and disease such that each of the dynamics and the disease
outcome may vary in different environments. In general, disease is a
product of host susceptibility and parasite pathogenicity in a given
environment. Susceptibility and pathogenicity each have two basic
components relating to the probability of infection and the host
fitness effects of infection. Host susceptibility is described by the
relative resistance to becoming infected, and the relative tolerance
of the host (controlling disease development [123]). Tolerance can
be described “as the ability to limit the health or fitness
consequences of a given parasite burden“ and can be statistically
quantified [241]. Likewise, parasite pathogenicity is described by the
relative ability to infect a host (infectivity), and the relative severity
of disease (virulence). Some studies predict the fixation of tolerance
genes in affected populations, and the maintenance of
polymorphism in resistance [123,242]. Disease control strategies can
manage for levels of resistance, tolerance, infectivity, or virulence.
Here, transmission is considered a component of infectivity.
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Figure 5 Abiotic and biotic factors affecting B. dendrobatidis
(Bd) zoospores. A) Bd zoospore attachment and encystment varies
with temperature in culture and is thought to alter infectivity [160].
B) The biotic environment can also alter Bd abundance. Shown here
is the effect of inoculated population size of grazing Daphnia on
the quantity of Bd zoospores over three days (A. Lauer, see
Appendix for methods).
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Mathematical models suggest that both individual
host-level and habitat-level treatments against Bd may
be effective management tools. The Briggs et al. [17,95]
models suggest that amphibian populations can recover
or persist in low abundance if some individuals lose
infection. The mathematical model developed by Mitch-
ell et al. [96] predicts that the longer the fungus is able
to survive in the water, the greater the impact on host
populations, suggesting that free-living stages of the
pathogen should also be targeted.
At present, we are unable to completely eliminate Bd
from an amphibian population or community because
we lack essential information about where Bd occurs in
the environment and how it spreads. Therefore, any
attempts to reduce the levels of Bd in an amphibian
population should be focused where success is most
likely: (i) where we have access to a considerable pro-
portion of the Bd population including infected hosts,
(ii) where the amphibian community is relatively simple
and/or (iii) where the habitat is relatively simple or iso-
lated such that treatments can be controlled (e.g. a
clearly delimited pond). Pilot treatment regimes in
mesocosms (C. Geiger, pers. comm.) and in natural
populations are making progress in Australia (M. Stock-
well, pers. comm.), California (V.T. Vredenburg and
R. Knapp, pers. comm.), and in Spain [5]. Treatments
include antifungal chemicals, salinity, and pond drying
to suppress Bd. Details of several ongoing studies can be
found in the appendix.
The characteristics that restrict Bd indicate potential
methods to manage Bd, such as creating areas of shal-
low water, canopy-free zones [97], or heating stations in
managed wetlands to increase host thermoregulatory
opportunities. Ecosystem engineering by beavers may
have similar effects on water temperature and can bene-
fit amphibian communities [98,99]. Re-creation of these
historically natural processes by human managers must
be done with care to avoid disrupting amphibian distri-
butions and by testing whether hosts are behaviorally
and phenotypically equipped to take advantage of such
measures [100]. Reducing Bd infection prevalence or the
probability of transmission to a level where amphibian
populations can coexist with the pathogen may require
repeated treatments; in many areas, continuing habitat
management is necessary to maintain viable amphibian
populations [40,101]. The conservation biologist’s tool-
box is becoming equipped for managing amphibians and
habitats with periodic physical or chemical treatments.
Reintroduction with assisted selection
Returning animals to the wild after extirpation is often
an attractive option for managers, especially in “pristine”
localities where the native fauna is protected and main-
tenance of the existing flora and fauna is mandated (e.g.
national parks and nature reserves). Such programs
include repatriation of rescued wildlife, translocation of
wildlife from a more prolific region, or reintroduction of
offspring that have been raised in captivity.
Reintroductions of amphibians have had mixed suc-
cess [101-104]. The programs can be expensive and
labor-intensive, and complicated by potential adaptation
to captivity, and the presence of disease in the captive
population or at the release site [104-106]. Many of
these challenges, however, can be addressed. For exam-
ple, to prevent genetic adaptation to captivity, breeding
programs can minimize the number of generations
produced before release, delay reproduction, or cryo-
preserve eggs and sperm if release is not imminent
[107,108]. When properly executed and monitored
[103,109,110] reintroductions have potential for success
(e.g. the natterjack toad, Bufo calamita reintroduction in
the U.K.[101]). Artificial selection has been successful to
improve resistance to viral and bacterial pathogens in
livestock [111,112] and in many fish species, i.e.
[113-115]. Incorporating disease resistance into amphi-
bian reintroduction programs may be desirable for
species threatened by chytridiomycosis.
Similar to fish, high fecundity and short generation
times of many amphibians may make them well-suited
to selective challenge with Bd, using survivors as breed-
ing stock for the next generation. Many amphibian spe-
cies, however, produce very few eggs or their captive
husbandry remains obscure. In these cases, a possible
alternative to selection by pathogen exposure is to select
for specific, measurable immunological characters that
have the potential to impart resistance. Gaining an in-
depth understanding of amphibian immunity is critical.
A strong candidate for this type of experiment would
be selection for effective antimicrobial peptides (AMPs;
[116]). Large quantities of AMPs are produced in the
skin granular glands of many amphibians as an invest-
ment in the innate immune system. The ability of
amphibian AMPs to inhibit Bd growth in vitro has been
shown to positively correlate with resistance to chytri-
diomycosis [117] and has been used to predict disease
susceptibility among species and populations [118,119].
Because AMPs can be collected by noninvasive techni-
ques and the amount and effectiveness of the peptides
produced by each individual can be assessed [120-122],
developing a screening process for individuals with the
most effective peptide repertoires has potential for use
with selective breeding.
This approach hinges on whether enhanced AMP
expression reduces susceptibility to chytridiomycosis
and whether the effectiveness or quantity of AMPs pro-
duced among individuals is variable and heritable. Evi-
dence is mounting to demonstrate these prerequisites:
An increase in Bd infection intensity resulted from
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reducing AMPs in young African clawed frogs, Xenopus
laevis [61]. AMP production changes little upon entry
into captivity [119], AMP expression is induced upon
pathogen exposure in some disease resistant species (D.
C. Woodhams, unpublished), and AMP expression is
both heritable and variable among individuals [119,122].
Immune defense genes such as those encoding AMPs
that allow for tolerance of Bd may be rapidly fixed in a
population [123,124]; whereas, the frequency of genes
allowing resistance to infection may fluctuate [116].
Although AMPs may have a role in both tolerance and
resistance, some species such as Panamanian golden
frogs, Atelopus zeteki, and boreal toads, Bufo boreas,
among others, do not appear to produce anti-Bd skin
peptides [125,126]. Other heritable defenses including
both innate and adaptive defenses [61,127,128] may be
better targets in these species, and such defenses may be
best identified in remnant populations (Figure 1).
In some cases, reintroduction programs can also bene-
fit from natural selection for disease resistance by focus-
ing on populations that have persisted beyond initial
outbreaks of chytridiomycosis. From such a population
at Peñalara Natural Park in Spain, founders from relict
metapopulations of midwife toads, Alytes obstetricans,
were captured after 10 years of successive and severe
mass mortality events. Natural selection has been shown
to occur even in such short time frames (e.g. [129]) and
surviving toads appear less susceptible to disease (J.
Bosch, unpublished). Similarly, in the Rocky Montains,
USA, some populations of boreal toad, Bufo boreas, per-
sist with disease [19]; the mechanism is unknown, but
some genetic lines have survival advantages [57]. By
attenuating disease-induced population declines long
enough for natural selection to produce disease resis-
tance, captive colonies and the problems associated with
artificial selection can be avoided. This strategy is being
employed in Australia for the critically endangered Cor-
roboree Frog, Pseudophryne corroboree. Field-collected
egg masses are raised in predator-free mesocosms to
head-start populations [130]. Preserving the full range of
amphibian habitats is essential for this strategy because
environmental conditions that allow hosts an advantage
over disease may occur in only a subset of habitats.
Climatic refugia and the management
implications of species rediscovery
Discovery and rediscovery boost the public perception
of conservation, often arousing imagination and hope
through positive media coverage [131]. Some rediscov-
eries are controversial, such as sightings of ivory-billed
woodpeckers in the Big Woods of Arkansas [132-134].
These rediscoveries have influenced the development
of guidelines for conservation listings [135] and criteria
for designating an organism as “extinct in the wild”
[136]. Such designations have significant management
implications.
Rather than obscure sightings or calls, several species
of amphibians have been captured after long absences,
making media headlines (Figure 1A). For example, a sis-
ter-species to the famous and extinct golden toad, Hol-
dridge’s toad, Incilius holdridgei, was also thought to be
extinct for 25 years until rediscovered in a Bd-enzootic
region of Costa Rica that formerly supported an abun-
dant population [137]. Most such rediscoveries are quite
recent, giving hope that more amphibian species
thought to be extinct may persist in the wild in a relict
population, perhaps in climatic refugia.
Climatic refugia may arise under two different situa-
tions, (1) areas where susceptible host species persist in
association with pathogens, or (2) areas where suscepti-
ble hosts persist outside the distribution of the pathogen
(Figure 1). Environmental conditions may suppress
disease development by decreasing pathogenicity (inhi-
biting pathogen growth or transmission), decreasing sus-
ceptibility (allowing effective host responses), or both.
These refugia, therefore, represent areas of high conser-
vation value since they may harbor source populations.
Species distribution models may help to identify climatic
refugia [138-141] (Figure 1).
As an example of the first situation, after the intro-
duction of avian malaria into Hawaii, several species of
birds persisted in high abundance in upland xeric habi-
tats where breeding capacity of mosquito vectors is lim-
ited in comparison with lowland mesic habitats where
bird populations crashed in association with disease
[142]. Since then, some species of endemic birds have
recovered, despite prevalent low-intensity chronic infec-
tions, suggesting that at least Hawaii amakihi, Hemi-
gnathus virens, have evolved tolerance to the pathogen
under climatic conditions favorable to disease transmis-
sion [143,144]. Remnant populations of disease resistant
birds in the lowlands may have been critical for recovery
[144].
A similar phenomenon may be occurring in some
amphibian populations. Many species with large ranges
across altitudinal gradients have declined to the point of
local extinction at upland sites but persisted in coexis-
tence with Bd at lowland sites [145,146]. Although mor-
tality still occurs at lower elevations, particularly when
environmental conditions are most conducive for dis-
ease development [147], lowland populations of suscep-
tible species of frogs persist with infection. For example,
lowland frogs on the east coast of Australia have
persisted with infection for at least 15-20 years since
the initial outbreaks of chytridiomycosis [30,147]. Popu-
lations of some susceptible frog species have recovered
and have begun to re-colonize upland sites from
which they were extirpated during initial outbreaks of
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chytridiomycosis [10]. Because of ongoing exposure to
Bd, selection on these frogs may have altered behavioral
patterns or enhanced immune functions such as antimi-
crobial peptide defenses [122], symbiotic microbial
communities, or adaptive immune defenses. If relict
populations successfully coexisting with Bd maintain
enhanced capacities for infection resistance or tolerance
compared to pre-decline populations, they could provide
the genetic resources for breeding resistance in survival
assurance colonies.
In amphibian populations that persist with Bd infec-
tions, the balance for host-pathogen coexistence may be
tenuous and these populations remain highly threatened
for several reasons. To begin with, relict populations that
survive initial declines often persist with dramatically
reduced abundances and are therefore vulnerable to sto-
chastic processes. If these populations persist in environ-
ments that are favorable for Bd growth (e.g., mid to high
elevation rainforests), Bd can have prolonged detrimental
effects on recovering populations [18,19,147,148] that
prevent the return to pre-decline abundances. Addition-
ally, these populations remain threatened by the intro-
duction of new and potentially more virulent strains of
Bd and their risk of suffering disease-induced extinctions
could be exacerbated by environmental change (even in
areas that are currently considered climatically-protected
areas [67,149]). Thus, continued management of core
habitat and adjacent areas will remain essential if these
depressed populations are to persist and recover in the
long run.
The current distribution of some species such as
Craugastor ranoides has developed in response to dis-
ease pressure. Within this group of closely related frogs
most species are extremely susceptible to chytridiomy-
cosis and have gone through significant declines, and
many are thought to be extinct [20,23,138,150]. The
high abundance of C. ranoides in the dry forest of Costa
Rica is an example of a second type of climatic refuge
that arises when there is little overlap between the dis-
tribution of the host and the pathogen (Figure 1). Iden-
tification of this type of climatic refuge is important for
potential managed relocation similar to that proposed to
combat biodiversity loss due to climate change [151].
For species presumed to be extinct in the wild, contin-
ued monitoring of historical sites and exploration of
adjacent areas remains an important task even after sig-
nificant periods with no sightings. Habitat protection
is crucial because without it, future rediscoveries of
“extinct” species might not be possible. Relict popula-
tions can also provide important insights; understanding
how they escaped pathogen exposure or survived the
initial outbreaks of Bd, and how they persist, despite the
presence of this pathogen, is key to developing effective
management strategies.
Immunization to fortify amphibians and
attenuating Bd for a live vaccine
Immunizing amphibians is perhaps one of the most
intuitive disease mitigation strategies. Immunization is
common in human and veterinary medicine; it has been
employed in efforts to eradicate rinderpest and foot and
mouth disease in ruminants [152], and against sylvatic
plague in black-footed ferrets [153]. In wild populations
this strategy works through herd immunity: producing a
threshold proportion of hosts that are resistant to infec-
tion in order to suppress disease outbreaks in sensitive
populations [154,155].
Immunization can be achieved through a variety of
processes that fortify amphibian immune systems
against Bd, either suppressing disease development or
preventing an infection. There are multiple lines of evi-
dence that suggest that an immunization strategy could
be successful either by attenuating Bd pathogenicity
for use as a live vaccine or by strengthening amphibian
resilience to pathogen exposure.
First, Bd virulence is known to vary among strains
[49,68,69]. The rapid range expansion of Bd may indicate
the emergence of a highly virulent strain that now predo-
minates [156]. Molecular studies indicate that genetic dif-
ferences exist among strains [69], and further research
may identify those that are inherently less virulent to sus-
ceptible amphibians [157]. Discovery or development of
an attenuated strain will hinge on resolving the mechan-
isms that result in hyper or hypovirulence. Promising
insights into these processes are emerging: A threshold
dose needed for infection and disease development is one
virulence mechanism common to many pathogens [158]
including Bd [17,53]. In fact, this “group effect” is even
apparent in isolation and culture of Bd such that single
zoospores or small clusters of sporangia do not readily
continue development [159]. Plasticity in Bd life-history
characteristics under different environmental conditions
may correlate with virulence [160,161]. Stable Bd life-his-
tory adjustments also occur in response to culture condi-
tions of temperature and nutrient availability [161].
Ongoing artificial selection experiments will determine
whether Bd virulence is amenable to changes in culture.
In addition to dose effect and life-history characteristics,
virulence can be attenuated in culture by heat or chemi-
cal treatment, or by genetic modification of some fungal
pathogens [162,163]. A low virulence stain of Bd may not
have a competitive advantage among strains unless it is
first to colonize the host and it stimulates host immunity
that prevents further infections.
Second, an untested hypothesis is that frogs normally
susceptible to chytridiomycosis, once cleared of infection
by manipulating environmental conditions or by chemi-
cal treatment [49,90,93,94], will have enhanced immu-
nity upon re-exposure to Bd. Murphy et al. [57] showed
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that boreal toads, Bufo boreas, can recover from a low
dose of Bd, however it is unknown whether recovered
individuals are more resistant to disease development
upon subsequent exposure. Amphibians can develop an
adaptive immune response against killed Bd injected
directly, but this response has not reduced susceptibility
to infection in the species studied (Bufo boreas [164]
and Rana muscosa [127]). In a recent study of disease
resistant African clawed frogs, Xenopus laevis, antibodies
were found in the skin mucous layer that bind to Bd
[61]. Future research directed at immunization protocols
to ramp up mucosal, rather than circulating, antibodies
in disease-susceptible amphibian species may be fruitful,
particularly to safeguard captive animals, although the
method lacks the potential to protect future generations
of non-immunized amphibians.
Habitat bioaugmentation and host biotherapy
Protective microbiota are potentially disrupted by
increasing environmental changes (e.g. habitat alteration,
climate change) equivalent to suppressing innate
immune defenses [165-167]. Thus, the microbiota asso-
ciated with an amphibian host or species may not be
capable of inhibiting Bd. To increase this capacity,
bioaugmentation or biotherapy is a strategy to add a
beneficial (probiotic) strain or consortium of microbiota
to amphibians or to their habitat for the purpose of
reducing host susceptibility to infection or disease
[168,169]. Usually the microorganisms applied in this
strategy are already or were historically present in the
habitat, rather than introducing new organisms to an
already stressed system. Biostimulation is a similar strat-
egy of adding nutrients or compounds (prebiotics) to
promote the growth of beneficial microbiota relative to
potential pathogens [170].
There is a long-standing practice of repeated bioaug-
mentation applications, including fungi, to prevent dis-
ease in agriculture [171,172]. Bioaugmentation with
another fungus or a hypovirulent strain of the same
pathogen may be useful to prime the host’s immune sys-
tem as in the semi-successful treatment of chestnut
blight (Cryphonectrua parasitica) in the U.S. by treat-
ment with an innocuous European strain [173]. Increas-
ingly, bioaugmentation is practiced in aquaculture and is
under development for ecosystem-wide restoration of
coral reefs [174]. In the later case, native coral-asso-
ciated microbial communities are capable of excluding
pathogens, producing biocides, and interfering with
pathogen cell signaling. There is mounting evidence for
a similar function of amphibian skin microbiota at
maintaining host health; bacteria such as Pseudomonas
spp. and Janthinobacter spp. are capable of suppressing
disease in some amphibians [50,51,89,175-180]. Simi-
lar to human gut microbiota, a specific microbial
consortium associates with amphibian skin and may
regulate host immunity ([181,182], L.R.D., E. Küpfer,
and D.C.W., unpublished data).
Restoring or enriching commensal microorganisms in
amphibian populations will involve studies on the diver-
sity of microbial consortia present in amphibian skin
and their environment, persistence of the microbial
communities over time, and modes of transmission.
Current laboratory trials are underway to assess Bd inhi-
bitory activity of symbiotic microbes and to test for
resistance to host antimicrobial peptides and other
defenses. Studies are progressing from the laboratory to
mesocosms, and in at least one case, to an emergency
bioaugmentation application in controlled field studies
for the critically endangered mountain yellow-legged
frog, Rana muscosa, in the Sierra Nevada, California
(R.N. Harris, pers. comm.; [183]).
A related strategy is to look for pathogens that specia-
lize on Bd and to apply these to infected frogs or habi-
tats. For example, pathogenicity of Cryphonectria
parasitica, the fungal agent of chestnut blight can be
reduced by mycoviruses. At least ten families of mycov-
iruses have been detected; their effects range from
decreasing to increasing the fitness and pathogenicity of
their fungal hosts. These viruses can be directly useful
for biocontrol of fungal pests on plants and have poten-
tial for use as gene vectors to modify fungal virulence
[184]. Mycoviruses of Bd have not yet been detected.
Biocontrol with predators of Bd
In addition to microbial competitors, Bd has natural
predators that could be used as biocontrol for disease.
In particular, microcrustacean zooplankton, such as
water fleas (Cladocera), copepods (Copepoda), and seed
shrimp (Ostracoda), are aquatic grazers and eat the
aquatic zoospores of some chytrid fungi [185]. Based on
this observation, zooplankton may be important ecologi-
cal regulators of Bd populations and reduce the risk of
amphibian infection in aquatic environments. Copepods
are successfully used as biological control agents in
other disease systems; for example, applications of Meso-
cyclops reduce populations of mosquito larvae suppres-
sing the vectors of Dengue Hemorrhagic Fever and
reducing disease incidence [186].
The efficacy of the biocontrol approach for chytridio-
mycosis will depend on clarifying the ecological interac-
tions of microcrustaceans in pond systems and testing
the hypothesis that microcrustaceans can influence Bd
population densities. Preliminary studies have found
that microcrustaceans reduce Bd zoospore densities in
laboratory culture experiments (Figure 5B). Isolated
microcrustaceans (cladocera - Daphnia sp. and ostra-
cods - Cypridopsis adusta), which are common in fresh-
water of ponds of the foothills of the Sierra Nevada and
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the Southern San Joaquin Valley [187], subsisted on only
Bd zoospores for seven days, while microcrustaceans in
cultures with no Bd zoospores died. Bd populations
were significantly reduced in these cultures. Even small
densities of Daphnia reduced zoospore populations
significantly (Figure 5B). However, it is not known if
microcrustaceans feed on zoospores when other food is
available. Future experiments will test zooplankton graz-
ing efficiency in mesocosms with alternative food
sources.
One hypothesis that links microcrustacean predation
with the ecology of Bd is that changes in microcrusta-
cean diversity could alter the population dynamics of Bd
in the water column and thereby influence disease
dynamics in amphibians. Diversity of microcrustaceans
appears to be declining in alpine lakes in California
[188-190]. Microcrustaceans are important components
of aquatic food webs worldwide; they are sensitive to
environmental changes and therefore excellent indicator
taxa for pollution (e.g. [191-193]), climate change and
introduced species [188]. Ongoing studies will character-
ize both the seasonal microcrustacean diversity in the
water column, and the historical diversity by examining
eggs surviving for up to several hundred years in the
sediment [194]. If the loss of microcrustacean diversity
is important to the disease dynamics of chytridiomyco-
sis, ponds with degraded communities that are Bd posi-
tive could be targeted for microcrustacean restoration
management.
Other strategies
Disease mitigation strategies are not limited to those
discussed here. It is worth pointing out that ultimately,
broader conservation practices aimed at minimizing
habitat modification, invasive species, atmospheric
change, and environmental pollutants will reduce the
need for downstream disease mitigation [195]. Mean-
while, integration of empirical studies and quantitative
modeling (Figure 6) enables strategic planning of man-
agement solutions.
Epizootiological models incorporating disease
control strategies
Epizootiological models can elucidate the dynamic pro-
cesses of infection, disease, and recovery at the indivi-
dual host level, and disease-induced fluctuations at the
population level. Disease control strategies can be incor-
porated into these models and simulations can be run
to test different scenarios. Figure 6A shows that the
growth rates of Bd can be manipulated by temperature.
Strategies that act to reduce the number of infectious
zoospores or slow the growth rate of the pathogen can
be combined with data on transmission efficiency and
rates of host immune responses. For example, Figure 6B
shows that slowing Bd growth or reducing zoospores
may allow time for host immune responses to reduce
infection burdens. Scaling up to the population level,
prophylactic treatments of naïve populations, or treat-
ments of populations with enzootic Bd may allow
amphibian population persistence without elimination of
infection or all cases of disease. In this scenario, re-
introductions of extirpated amphibians can begin before
eliminating risk of Bd infection. These scenarios were
modeled for Rana muscosa populations that either go
extinct or persist with low infection burdens but high
prevalence [180], and indicate that persistence is possi-
ble if some adults can survive infection and reproduce
[95]. Additional context-specific modeling can help to
assess hypotheses prior to field implementation of miti-
gation techniques. The reproductive success of addi-
tional species may depend on herd immunity thresholds.
Lam et al. [196] suggest a herd immunity threshold of
approximately 80% in Rana muscosa populations
exposed to Bd. If at least 80% of frogs are protected
from disease by anti-Bd microbial symbionts, then the
population can persist following disease emergence or
introduction. This estimate provides several epizootiolo-
gical insights. For example, the basic reproductive rate
(R0), or number of new infections arising from an
infected frog arriving at a pond, a measure of parasite
fitness, must be less than 5 in a basic SI model where
proportion protected, p > 1 - (1/R0). In a population
estimated at 200 individuals, and given density depen-
dent transmission, the maximum transmission efficiency
(b) would be no greater than 5/200 = 0.025 new infec-
tions per day. If correct, experimentally reducing trans-
mission efficiency below this threshold should prevent
host decline in response to disease emergence.
Ecological Ethics of Amphibian Disease
Management
Ecologists and conservationists working on disease miti-
gation experiments bear the ethical burdens both to act
urgently on behalf of threatened biodiversity and to
avoid excessive ecological risk or animal suffering.
These responsibilities can be balanced within an ecologi-
cal ethics framework [197,198] which blends guidance
from multiple stakeholders, effectively diffusing the ethi-
cal burden on the experimenter. Consideration for ani-
mal welfare, the welfare of the environment, the
concerns of funding agencies, parks and wildlife agen-
cies, and public perception merge on an ethical course
of action (Figure 7). An appropriate ecological ethics
framework garners respect for the practice of conserva-
tion biology and enthusiasm for experimental disease
mitigation projects without lingering moral fears.
Approval and permitting systems are in place in many
countries that provide these services to scientists, but
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continued bioethical thought is needed for emerging
questions:
► What is the best management practice for rediscov-
ered populations consisting of very few individuals?
► What level of risk is warranted to reduce the untold
suffering of wild amphibians succumbing to disease and
the destructive downstream ecosystem cascades?
► What are the critical biotic components that must
be considered before using treatments aimed at saving
amphibian populations from catastrophic decline?
► What scale of application is appropriate for disease
mitigation strategies that alter natural habitats, biotic
communities, or host genotypes?
► Are live vaccines or genetically altered pathogens
ethically viable options for wildlife disease mitigation?
Ethical science, public participation, education, and the
political-values struggle are intertwined with conservation
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frogs, the frogs’ average fungal load (solid red line) increases rapidly to Smax, and the population goes extinct. In the treated population, the frog
density is reduced to 10 frogs on day 30. The rates of increase of Bd both in the zoospore pool and on the frogs (dashed blue line = average S
per frog) are decreased, and the frogs’ immune response (dotted green line = average antibody level per frog) is able to suppress the infection
before Smax is reached.
Experimental 
Disease Mitigation 
Strategy
Environmental 
Welfare
Animal 
Welfare
Public 
Approval
Management 
Agency 
Approval
R
es
ea
rc
h 
Fu
nd
in
g
Professional ethics
Environmental and animal ethics
R
es
ea
rc
h 
et
hi
cs
Strategies to maintain wild 
amphibian populations and 
control chytridiomycosis:
► Reducing host density 
► Host treatment and release
► Habitat treatment 
► Climatic refugia
► Selective breeding 
► Immunization
► Bioaugmentation with native microbiota
► Biotherapy
► Biocontrol with natural predators
Figure 7 Ecological ethics framework [197,198] supporting
experimental disease mitigation strategies aiming to reduce
Bd pathogenicity or amphibian host susceptibility and to allow
long-term population persistence and co-evolution with a
potentially lethal pathogen.
Woodhams et al. Frontiers in Zoology 2011, 8:8
http://www.frontiersinzoology.com/content/8/1/8
Page 12 of 23
efforts in general [199,200]. Grass-roots support is critical
to facilitate action through media campaigns and fund
raising once the best conservation strategies are deter-
mined, and this is growing thanks to groups like Save the
Frogs, Amphibian Ark, World Association of Zoos and
Aquariums, and others [201,202]. With this firm footing,
we can meet the challenge of rescuing amphibian
diversity.
Conclusions
The literature describes a variety of disease mitigation
strategies that can be applied to amphibians. These
include, but are not limited to, reducing host density,
treating hosts and habitats, reintroductions with assisted
selection, utilizing climatic refugia, immunization, habi-
tat bioaugmentation and host biotherapy, and biocon-
trol. Beyond maintaining existing biodiversity, many of
these strategies aim to reverse the processes of environ-
mental degradation with a restoration ecology approach.
By recognizing the opportunistic nature of Bd and com-
bining this knowledge with epizootiological models,
mitigation strategies can be designed to control disease
without the need to completely eliminate the pathogen
from the environment.
Conservation biologists should prepare for more active
management of amphibian disease on a scale ranging
from host to habitat, and varying in approach from
medical to ecological. Under development are periodic
physical or chemical treatments and methods to limit
infectious zoospores in the environment resulting in
reduced disease spread or reduced pathogen prevalence
or infection intensities. Managing for both abiotic and
biotic habitat characteristics may be critical given that
healthy microcrustacean communities may actively pre-
date Bd zoospores and reduce transmission. Altering
amphibian density through culling may not be effective.
Refugia where threatened and susceptible species persist
must be actively targeted for conservation since they
contain the remnants of within-species diversity and
potential sources for population recovery, as well as
space for potential managed relocation. If recovered or
re-colonized populations have evolved increased disease
resistance as with other wildlife epizootics [203,204],
studying them may reveal new mechanisms for reducing
the impact of the disease and suggest strategies for
increasing the disease resistance of captive-bred frogs
prior to reintroduction. Assisted selection within captive
amphibian colonies has long-term potential. Attenuated
Bd or an avirulent strain could be used as a live vaccine,
and perhaps in wild populations after ameliorating the
risks of evolving greater virulence. Molecular advances
illuminating virulence mechanisms may enable genetic
modification of Bd and immunogenetics studies may
reveal avenues for enhancing immune responses to Bd
infection [128,205]. Immunization protocols targeting
mucosal immunity are needed and could benefit from
the process of recovery from an initial infection.
Biotherapy has been proven to increase host immunity
and may be transmissible within a population or
between populations. This hopeful proof-of-concept
requires testing on a larger scale. Treatment of indivi-
dual hosts at the front of an epizootic may slow the
spread, allow time for acquired immunity to develop
[94], or suppress disease outbreaks through herd immu-
nity. To test these diverse strategies, a step-wise adaptive
management approach with continued population and
disease monitoring is the best hope for effective disease
management. Various combinations of these disease
mitigation strategies and creative local solutions are
likely to emerge for the stewardship of wild amphibian
populations into the future.
Appendix
Here we provide further details of the ongoing experi-
mental tests of mitigation strategies and of the mathe-
matical model presented in Figure 6. Case studies
include: (1) treating individuals, (2) treating pond habi-
tats with fungicides, (3) treating pond habitats by drying,
(4) reintroductions with disease monitoring, and (5) bio-
control with microcrustaceans.
Ongoing case studies
1. Treatment and release (Alytes obstetricans, Spain and
Switzerland)
In the Peñalara Natural Park (Madrid, central Spain),
the first known chytridiomycosis outbreak in Europe
rendered the population of Alytes obstetricans close to
extinction [206]. Tadpole abundance dropped remark-
ably in successive years (e.g. from more than 5000 to 20
in the pond holding the largest population), considerably
increasing the value of each tadpole. Dead or sick adults
have never been found in the area, while thousands of
dead or dying metamorphs could be easily found. Thus,
experimental treatments were restricted to tadpoles.
Pilot tests by J. Bosch (National Museum of Natural
Science in Madrid, Spain) verified that tadpoles infected
with Batrachochytrium dendrobatidis (Bd) survived after
metamorphosis when kept in captivity at more than 21°
C, a temperature higher than ambient field conditions.
Therefore, every single tadpole found in the area was
collected and kept in the laboratory at high temperature.
Metamorphosed animals were then released, even
though some of them tested positive for Bd by qPCR at
the time of release. Prior to release, intensive surveys
yielded no metamorphs in the wild. In 2009, the thermal
treatment was replaced with itraconazole baths [93], and
detailed studies on infection status and survival of
released animals are now in progress. Re-infection of
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treated animals is possible for both kinds of treatments,
and it is too early to recommend its use given the risk
of Bd acquiring resistance to itraconazole.
With the possibility of complete extirpation of A.
obstetricans in Peñalara Natural Park following out-
breaks of chytridiomycosis, a captive-breeding program
was established in 2008 by the local government of
Madrid, the Museum of Natural History of Madrid
(CSIC) and the Durrell Wildlife Conservation Trust.
Although the main objective of the program is to main-
tain a captive breeding colony in case of extinction in
the wild, the colony also provides a source for reintro-
ductions. Animals were extremely scarce such that find-
ing founders was difficult. However, because founders
were captured from relict metapopulations after 10
years of successive mass mortalities, natural selection
has likely occurred. Specifically, it is possible that survi-
vors carry genes fixed by natural selection that confer
tolerance (better able to reduce the consequences of
infection) rather than resistance (better able to resist Bd
infection [123]). When offspring are produced, decisions
will have to be made about selectively breeding for tol-
erance or resistance. Presently, we have an incomplete
understanding about which components of the host
response lead to prevention of infection, elimination of
Bd, or resolution of disease.
A similar approach is being followed by C. Geiger and
B.R. Schmidt (University of Zurich, Switzerland). They
collected over-wintered A. obstetricans tadpoles from
several ponds. The ponds were relatively simple, man-
made ponds with amphibian communities consisting of
two newt and two anuran species in addition to Alytes
obstetricans. The tadpoles were taken to the laboratory
and treated against Bd using itraconazole [93]. A. obste-
tricans tadpoles were selected as a model to test mitiga-
tion strategies against Bd because they are thought to be
a significant Bd reservoir. Other amphibian species in
the ponds were not treated. Previous mesocosm experi-
ments showed that very few A. obstetricans tadpoles
treated with itraconazole became re-infected. This was
the case even when they were put back into mesocosms
where infected conspecifics were present (C. Geiger and
B.R. Schmidt, unpublished data).
2. Pond-level treatments - fungicides (Switzerland)
At the University of Zurich, Switzerland, C. Geiger and
B.R. Schmidt conducted mesocosm experiments in
which they tested whether pond-level treatments against
Bd are feasible. The use of fungicides is a common
method to control fungal pathogens in medicine and
agriculture, but Kilpatrick et al. [207] described the use
of antifungal compounds in natural wetlands to com-
bat Bd as “radical”. Nevertheless, methods developed
in aquaculture may be particularly useful for the
development of methods to control Bd in natural ponds
through the use of fungicides.
Laboratory experiments showed that commonly
employed anti-fungal chemicals used in aquaculture and
by fish hobbyists can clear Bd infection in tadpoles of
the midwife toad Alytes obstetricans (C. Geiger and B.R.
Schmidt, unpublished data). Mesocosm experiments
were used to learn whether antifungal chemicals are
also effective at eliminating Bd from experimental tad-
pole communities under more natural conditions and
how they affect the pond ecosystem. For example, fungi
are important decomposers and primary producers in
pond food webs [208] and we need to know how the
use of fungicides affect ecosystem functions and ser-
vices. While direct effects of fungicides on pond organ-
isms may be negligible, indirect effects may have strong
negative effects [209]. Even if Bd could be eliminated
from natural environments using fungicides, environ-
mental regulations may prevent the use of fungicides in
wetlands.
3. Pond-level treatments - drying (Alytes muletensis, Spain)
Drying the habitat containing pathogens can reduce dis-
ease incidence. Kriger and Hero [210] showed that Bd
occurs primarily in permanent ponds but was absent
from ephemeral ponds. Thus, draining ponds may be a
way to suppress Bd in the environment. Because many
amphibian species are adapted to ephemeral habitats,
draining ponds may not affect amphibian populations
negatively [211], especially when done late in the season
when tadpoles are no longer present. If the timing of
pond drying can be managed, temporary natural or con-
structed ponds offer a feasible option for managing
amphibians impacted by disease. The construction of
temporary ponds is already advocated as an amphibian
conservation strategy in highly urbanized areas in Eur-
ope [212] and is used as a remediation measure in the
United States.
Midwife toads (genus Alytes) are probably the most
Bd susceptible species in Europe [35,36,206]. Tadpoles
have long lifespans (often more than one year), allowing
them to be in permanent contact with zoospores. Adults
are highly terrestrial and only males approach the water
to release egg clutches. Infected populations of Mallor-
can midwife toads, Alytes muletensis, seem to be appro-
priate targets to explore mitigation approaches for
several reasons. Populations are contained in a very dry
environment which forces animals to move along tor-
rents and impedes migration among different basins
[213]. In addition, no other amphibian species co-occur
with A. muletensis, and pools holding tadpoles are small
and relatively free of organic material.
The first attempt to eliminate Bd from an A. muleten-
sis infected population is in progress [5]. In this attempt,
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both individuals and the habitat are being treated. The
target pool consists of two small cisterns created for
watering live-stock in a short torrent gorge. The Mallor-
can midwife toad is the only amphibian species inhabit-
ing the pool, and the scarcity of aquatic vegetation,
rocks or mud allow the capture of every tadpole. In sev-
eral visits during a 6-month period, all tadpoles were
collected and taken to the laboratory, where they were
treated with itraconazole following Garner et al. [93].
Field work started before the breeding season with col-
lections of over-wintered tadpoles and continued until
no new egg-clutches were found and every tadpole was
collected. The pool was completely drained. Treated
tadpoles were then put back into the pool after the first
autumn rains. We expected that the Bd population
would not recover once its main tadpole reservoir had
been successfully cleared of infection and the ponds
dried. However, results from spring of 2010 indicate
that reintroduced tadpoles contracted Bd infections, but
infections were of a lower intensity. Thus, continued
eradication efforts will target adults as well as larvae in
the area [5].
4. Reintroductions of Bufo boreas
Boreal toads have been extirpated from 75% of sites
inhabited historically in Rocky Mountain National Park
(RMNP) and have declined precipitously in the south-
ern Rocky Mountain Region [214]. In 2007, RMNP
launched a thoughtfully planned effort to reintroduce
boreal toads. The site was chosen in a region within
the park that was historically inhabited by boreal toads
[215]. Donor toads were offspring of toads collected in
the park and bred in captivity. After three years of sur-
veys, sites were selected based on habitat suitability
[216], proximity to existing toad populations, proximity
to human activities, logistical considerations, and dis-
ease status. Using molecular methods, disease status
was determined from skin swabs of boreal chorus
frogs, Pseudacris maculate, and wood frogs, Rana
sylvatica [217] and from water samples [218]. Bd was
not detected at the selected site. Introductions of tad-
poles were initially planned for 3 - 5 years. The project
has thus far released tadpoles (700 - 14,000) in three
consecutive years (2007-2009), and seven adults in
2008. The adults were excess hatchery individuals and
released as an opportunity to assess their usefulness as
sentinels for disease. These individuals were monitored
using radio telemetry and swabbed weekly between
June and September. Diagnostic skin swabs revealed
the presence of Bd in ~30% of sentinels, indicating
that Bd is still present in the area. In 2009, a handful
of one and two year old toads were located at the
site. Future releases are planned with extensive moni-
toring to quantify the success of the reintroduction
program.
From this effort, we learned that adults can be effec-
tive sentinels for Bd presence, and that continued moni-
toring is extremely important. Monitoring is often
the most neglected part of a translocation project
[103,110,219] and becomes especially critical when deal-
ing with a transmissible disease and animals that may
move relatively long distances. Monitoring is essential
and provides information to specify management goals
and articulate research hypotheses [220]. As we learn
more about the efficacy of mitigation measures, a sound
monitoring protocol will be imperative both for disease
surveillance and population assessments.
5. Biocontrol with microcrustaceans
The littoral zone of ponds and lakes is a complex area
with multiple interactions between biotic and abiotic
factors. Especially predator-prey interactions of fish or
crayfish and zooplankton, and zooplankton grazing/
filter-feeding on smaller microorganisms form a contin-
uous and interdependent cycle over the seasons. The
introduction of fish and algae/cyanobacteria into these
ecosystems or changes in abiotic factors (pH, chemicals,
nutrients, temperature) can destroy established food
chains and result in the disappearance or overabundance
of some species. The disappearance of cladocerans from
Lake Tahoe, CA, in the early 1970’s, for example, was
linked with high densities of introduced opossum
shrimp (Mysis relicta) and kokanee salmon (Onchor-
ynchus nerka) [221]. A recently study performed by
Koksvik et al. [222] also correlated a reduction in clado-
ceran biomass to the introduction of mysids at Lake
Jonsvatn, Norway. Whereas cladocerans were highly
affected by introduced fish and shrimp, copepods were
not or were less negatively impacted (same study).
As filter-feeding organisms, microcrustaceans can be
natural predators of Bd zoospores which are 3-5 μm in
size and contain valuable nutrients, especially lipids
[223]. The size of food particles successfully filtered
depends on the filter apparatus of the microcrustacean
species [224]. Furthermore, some microcrustaceans have
food preferences and are able to actively select between
different food particles [225]. Kagami et al. [185,226]
showed that Daphnia sp. were feeding on zoospores of
the chytrid pathogen (Zygorhizidium planktonicum) of
the diatom Asterionella formosa.
At the Environmental Studies Area (ESA) at California
State University Bakersfield, A. Lauer isolated different
microcrustaceans (cladocerans, copepods, and ostra-
cods). These were cultured in freshwater supplemented
with ‘green water’, especially Chlorella sp. as a food
source (L.F.S. Cultures, Oxford, MS). The microcrusta-
ceans were incubated at 15°C in an incubator (Percival
E-30B) with a 12 h day (40 μmol quanta m-2s-1) and
12 h night cycle and were growing and multiplying well
under these conditions. Cultures of Bd (JEL213,
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obtained from J.E. Longcore, University of Maine) were
successfully grown in liquid 1% tryptone medium
at 18°C.
In an initial experiment, six Daphnia sp. individuals
from ESA were incubated together with ~1.5 × 105 Bd
zoospores/ml in 5 ml of sterile freshwater (0.22 μm filter
sterilized) in wells of a 6-well plate (max. vol. 10 ml)
over a period of seven days in comparison to a negative
control were no Daphnia were added, and a control
were only Daphnia were present, but no Bd zoospores.
The experiment was performed in an incubator at 15°C
with a day night cycle (12 h under 40 μmol quanta m-
2s-1). Prior to the experiment, the Daphnia individuals
were rinsed three times with sterile freshwater [227] to
remove transient microorganisms that could be used as
a food source. The same experiment was performed
with a local ostracod species (seed shrimp, Cypridopsis
adusta), isolated from the same environment as Daph-
nia sp. (pond at ESA at CSUB). The species of Daphnia
used in this experiment still needs to be confirmed.
Based on microscopic observations it was most probably
D. rosea or D. galeata.
After the end of the experiment (day 7), all microcrus-
taceans that were incubated together with Bd zoospores
were still alive at the end of the experiment, whereas all
microcrustaceans without zoospores as a food source
died. The well with Bd zoospores alone had formed
clusters of zoosporangia visible with the naked eye.
Microscopic investigations proved that the amount of
Bd zoospores was under the detection limit in the wells
were microcrustaceans had been present. This experi-
ment demonstrated that the two species of microcrusta-
cean tested were actively feeding on Bd zoospores.
Based on this observation, a second exposure experi-
ment was set up where different amounts of Daphnia
individuals (0, 4, 8, 12, 16, 20, and 24) were exposed to
the same amount of Bd zoospores (~1.6 × 105 spores/
ml) over a period of three days in 15 ml of sterile fil-
tered freshwater in sterile collection containers (max.
vol. 50 ml) under the conditions described in the pilot
experiment. Overall, every 1.5 h a sample of 200 μl was
taken which added up to five samples taken each day.
The experiment was continued for two more days, tak-
ing samples during the day and leaving them untouched
during the night. Bd zoospores were stained with Mala-
chite green (a spore stain) and counted using a Phase
Contrast Microscope (Nikon, type 104) with 400 × mag-
nification and a Neubauer counting chamber.
Even though the initial number of Bd zoospores/ml
were supposed to be ~1.6 × 105/ml, the numbers varied
from 2.3 - 4.2 × 105/ml at the beginning of the experi-
ment. This is probably due to clusters of zoospores that
were initially counted as one and then broke apart when
the Bd-dilutions were prepared. A decline in number of
Bd zoospores was observed for all trials with a steeper
decline when 12 and more Daphnia were present in
comparison to the control where no Daphnia were
added to the zoospores (Main text, Figure 5B). After the
steep decrease in zoospores on day one of the experi-
ment, the zoospore count stabilized or declined moder-
ately over the next two days (Main text, Figure 5B). It
was observed that the Daphnia individuals started
reproducing in all containers on day 3 of the experi-
ment. Three counts of zoospores were combined and an
average calculated for each sample investigated. The
exact amount of Daphnia individuals at the end of the
experiment, their size and biomass was not determined.
In an ongoing project, A. Lauer has begun studying
the diversity of microcrustaceans and the presence of
Bd in different ponds of the Southern San Joaquin Val-
ley and the foothills of the Sierra Nevada (CA), compar-
ing the diversity in the spring and fall. In addition to
investigating the microcrustaceans present in the water-
column, sediment samples were analyzed with molecular
methods for the presence of diapausing eggs, which are
known to survive for hundreds of years [194]. A discre-
pancy between the diversity of microcrustaceans in the
watercolumn to the one in the sediment might indicate
a shift or decline in diversity of microcrustaceans due to
environmental influences, such as pollution, eutrophica-
tion, invasive species, including the introduction of fish.
Details of Mathematical Models
Figure 6 extended legend
(A) Diagram of the Briggs et al. [17] model. The model
follows the dynamics of the zoospores (Z) in a zoospore
pool, and the sporangia (Si) on each frog i. Copied with
permission from Proceedings of the National Academy of
Sciences. (B) Examples of conservation strategies without
an adaptive immune response. Shown here are the fungal
loads on a frog in a constant pool of zoospores. In (a), if
the frog remains untreated, its fungal load will hit Smax =
10000 sporangia in 33 days and the frog will die. The
default parameters are: ν = 0.25, g*Z = 500 zoospores/day,
h*f = 1 zoospores/sporangia/day, s = 0.2/day, S(0) =
1 sporangia. In (b)-(d), treatments are applied on day 20.
In (b), the zoospore pool is eliminated (g*Z = 0) on day 20.
This extends the life of the frog by slowing the rate of
increase of the fungal load on the frog, but for the default
parameters, the fungal load continues to build up due to
self re-infection. In (c), constitutive defenses of the frog
are increased on day 20, perhaps through the application
of probiotic bacteria (the fraction of zoospores that suc-
cessfully infect the frog, ν, is decreased to 0.15 on day 20).
This is sufficient to allow the frog to eventually clear the
infection. In (d), both types of treatments are applied
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(on day 20 the frog is removed from the zoospore pool,
g*Z = 0, and exposed to probiotic bacteria that reduce n to
0.15) and the rate of recovery of the frog is increased.
(C) Examples of a treatment strategy if the frog has an
effective adaptive immune response. The solid red line
shows the fungal load on an untreated frog in a constant
pool of zoospores. The fungal load builds up rapidly and
reaches the lethal threshold on day 33. The dashed blue
and dotted green lines show the fungal load and antibody
levels if on day 30 the frog is treated with an anti-fungal
agent (such as itraconazole), which temporarily reduces its
fungal load to zero. The fungal load builds up again, but
the initial exposure has resulted in sufficient antibodies
that the peak fungal load is below the lethal threshold.
The fungal load on the frog eventually reaches a stable
level of 916 sporangia. The parameters used are g*Z = 1
zoospores/day, h*f = 1 zoospores/sporangia/day, s = 0.2/
day, S(0) = 0 sporangia, p = 0.5, and θ = 0.1/sporangia. (D)
The parameters used are g = 1 × 10-4/day, h = 9 zoos-
pores/sporangia/day, f = 0.1, s = 0.2/day, Si(0) = 0 sporan-
gia, Z(0) = 10,000 zoospores, p = 0.5, and θ = 0.1/
sporangia.
Model of infection on a single frog without adaptive
immunity
The basic Briggs et al. [17] model of the interaction
between Bd and an amphibian host followed the
dynamics of the number of sporangia S(t) on each frog
in a zoospore pool, Z(t). Here we make the simplifying
assumption that a single frog in a large population of
frogs will not significantly affect the level of zoospores
in the zoospore pool. We instead follow the dynamics of
the number of sporangia S(t) on a single frog in an
infected population where the density of zoospores is
set to a constant value, Z.
The model becomes:
dS/dt = ν(γ /V)Z + ηνfS− σS
where the parameters are defined as in Briggs et al.
[17]:
g = encounter rate between zoospores and frogs in a
pool of volume V
ν = fraction of encounters between zoospores and
frogs that result in infection of the host (and creation of
a new sporangium)
h = release rate of zoospores from each sporangium
f = fraction of released zoospores that immediately
infect the same host
s = loss rate of sporangia from a host (such that 1/s
is the average lifespan of a sporangium)
This can be re-written as:
dS/dt = b + a S,
where b = ν(g/V) Z is the rate of addition of sporangia
to the host from the environment,
and a = (hνf- s) is the per-sporangia rate of increase
of sporangia in the absence of contributions from the
environment.
The solution to this equation, giving the number of
sporangia on the frog at any time t, as a function of the
initial condition, S(0) = number of sporangia on the frog
at time t = 0, is:
S(t) = (a S(0) exp{a t} + b exp{a t} − b)
The per-sporangia rate of increase of sporangia in the
absence of contributions from the environment, a = (hνf -
s), can be either positive or negative. If a < 0, then the
number of zoospores on the frog reaches a stable equili-
brium at S* = -b/a, with the frog continually being infected
from the zoospore pool. If a>0, then the frog can effec-
tively re-infect itself, and number of zoospores on a frog
grows without bounds. If there is a threshold fungal load
Smax above which the frog dies, then with a>0 the sporan-
gia will inevitably surpass this threshold and die due to
chytridiomycosis.
Model of infection on a single frog with adaptive
immunity
We developed a model of a hypothetical adaptive
immune response to Bd infection. It has not yet been
demonstrated conclusively that amphibians are able to
mount an effective adaptive immune response against
Bd, although the possibility of such a response remains.
To date there have been no published experiments doc-
umenting that prior exposure to Bd reduces either the
susceptibility of frogs to Bd infection or the impact of
Bd on infected hosts (but see [61]). Recent gene expres-
sion studies [60,205] have failed to find evidence of up-
regulation of genes associated with adaptive immunity
in Bd-infected frogs compared to uninfected controls,
although such studies have been conducted only on
Silurana (Xenopus) tropicalis, which is highly susceptible
to Bd. Much more work is needed on adaptive immu-
nity against Bd, and several efforts are underway to
develop the necessary tools to make this possible (L.A.
Rollins-Smith, E.B. Rosenblum pers. comm.). At this
point, the model of adaptive immunity presented here is
purely speculative.
To the Model of infection on a single frog without
adaptive immunity described above, we add a second
equation that describes the dynamics of a hypothetical
mucosal antibody, A, that is produced in response to Bd
infection. We assume that the rate of production of
antibody is proportional to the number of sporangia on
the frog (with rate parameter r), and that in the absence
Bd infection, the level of antibody in the frog would
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decay exponentially (at rate c). Here we assume that the
antibodies are mucosal antibodies that kill off zoospores
that encounter the frog skin such that the fraction of
zoospores that successfully infect the frog, ν, is no
longer a constant but is a function that decreases with
increasing antibody level.
The equations describing this model are:
dS/dt = ν(A)(γ /V) Z + ν(A)ηfS− σS
dA/dt = r S− c A
with ν(A) = p*exp(-θ A)
where p = the fraction of encounters between zoos-
pores and frogs that successfully infect the frog when no
antibodies are present.
θ = rate at which the fraction of zoospore that suc-
cessfully infect the frog decreases with increasing anti-
body titer.
Population-level model of infection with adaptive
immunity
To model a population of frogs with adaptive immunity
in a zoospore pool, we follow the dynamics of the num-
ber of sporangia Si and antibody level Ai on each frog i.
We assume that each frog contributes zoospores to, and
becomes infected by, zoospores from a common zoospore
pool, Z. We follow the assumption on Briggs et al. [17]
that a fraction f of the zoospores that are released from
each sporangium on frog i immediately re-encounters the
same frog (and needs to get past the frog’s defenses),
with probability νi(Ai), and the remaining fraction (1-f)
enters the zoospore pool.
dSi/dt = νi(Ai)(λ/V) Z + νi(Ai)ηfSi − σS
dAi/dt = r Si − c Ai
dZ/dt = η(1− f)Stot − (γ /V)Z N− μZ
with νi (Ai) = p*exp(-θ Ai) and Stot = total number of
sporangia on all frogs at time t for all frogs i = 1...N,
where N is the current density of frogs.
Frog i dies (and N is decreased by 1) when its fungal
load, Si, reaches Smax.
Here we present results of only the deterministic ver-
sion of the model, in which all frogs with the same
initial fungal loads follow identical trajectories.
The model as written does not include birth of frogs,
or death due to causes other than chytridiomycosis, and
is meant to describe the dynamics within a single year
in a frog population in a temperate region. Frog demo-
graphy can be included in a number of different ways, e.
g. [17]. This model also includes only a single species of
frog. It could be easily expanded to include multiple
frog species, each contributing zoospores to separate,
overlapping, or a common zoospore pool(s).
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